Government ContextGovernment Context
ActivityRulesGrantsPress releasesHearingsBills
ViewsAgenciesTopicsOrganizationsCommitteesLegislators
PricingLog inCreate account

Table of contents

DetailsOverviewExplorerRelated

PSG_214231 - Draft Guidance on Dasiglucagon Hydrochloride

FDA-2007-D-0369-2613Other
Comments
0
Awaiting comments
Deadline
61 days
Closes Sep 29, 2026
Net supportiSupport minus oppose · campaigns included
—
Document

Details

The document's own metadata, straight from the source system.

Title
PSG_214231 - Draft Guidance on Dasiglucagon Hydrochloride
Posted
Jul 29, 2026
Comment period
Jul 29, 2026 – Sep 29, 2026
Agency
Food and Drug Administration (FDA)
Topics
View on regulations.gov ↗
Analysis

Overview

No comments yet — comment period open · 61 days left.

Comments

Explorer

Every mirrored comment — filter by stance, campaign, or issue.

Filter:

No comments match.